Follow
Zoltan Griger
Zoltan Griger
immunológus, reumatológus, belgyógyász, Debreceni Egyetem
Verified email at med.unideb.hu
Title
Cited by
Cited by
Year
A hot new twist to hair biology: involvement of vanilloid receptor-1 (VR1/TRPV1) signaling in human hair growth control
E Bodó, T Bíró, A Telek, G Czifra, Z Griger, BI Tóth, A Mescalchin, T Ito, ...
The American journal of pathology 166 (4), 985-998, 2005
2452005
Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren's syndrome
E Zilahi, T Tarr, G Papp, Z Griger, S Sipka, M Zeher
Immunology letters 141 (2), 165-168, 2012
1502012
Four dermatomyositis-specific autoantibodies—anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5—in adult and juvenile patients with idiopathic inflammatory myopathies in a …
L Bodoki, M Nagy-Vincze, Z Griger, Z Betteridge, L Szöllősi, K Dankó
Autoimmunity reviews 13 (12), 1211-1219, 2014
1102014
Transient receptor potential vanilloid-1 signaling as a regulator of human sebocyte biology
BI Tóth, T Géczy, Z Griger, A Dózsa, H Seltmann, L Kovács, L Nagy, ...
Journal of Investigative Dermatology 129 (2), 329-339, 2009
982009
Trial of intravenous immune globulin in dermatomyositis
R Aggarwal, C Charles-Schoeman, J Schessl, Z Bata-Csörgő, ...
New England Journal of Medicine 387 (14), 1264-1278, 2022
762022
C1-inhibitor autoantibodies in SLE
T Mészáros, G Füst, H Farkas, L Jakab, G Temesszentandrási, G Nagy, ...
Lupus 19 (5), 634-638, 2010
622010
Retrospective analysis of cancer-associated myositis patients over the past 3 decades in a Hungarian myositis cohort
C András, L Bodoki, M Nagy-Vincze, Z Griger, E Csiki, K Dankó
Pathology & Oncology Research 26, 1749-1755, 2020
422020
Pharmacological management of dermatomyositis
Z Griger, M Nagy-Vincze, K Dankó
Expert Review of Clinical Pharmacology 10 (10), 1109-1118, 2017
272017
Abnormal Cell‐Specific Expressions of Certain Protein Kinase C Isoenzymes in Peripheral Mononuclear Cells of Patients with Systemic Lupus Erythematosus: Effect of …
T Bíró, Z Griger, E Kiss, H Papp, M Aleksza, I Kovács, M Zeher, E Bodolay, ...
Scandinavian journal of immunology 60 (4), 421-428, 2004
272004
Dysregulated expression profile of myomiRs in the skeletal muscle of patients with polymyositis
E Zilahi, Z Adamecz, L Bodoki, Z Griger, S Póliska, M Nagy-Vincze, ...
Ejifcc 30 (2), 237, 2019
252019
Platelet microparticles enriched in miR-223 reduce ICAM-1-dependent vascular inflammation in septic conditions
B Szilágyi, Z Fejes, Á Rusznyák, F Fenyvesi, M Pócsi, S Halmi, Z Griger, ...
Frontiers in Physiology 12, 658524, 2021
232021
Vitamin D receptor gene polymorphisms and haplotypes in Hungarian patients with idiopathic inflammatory myopathy
L Bodoki, JQ Chen, M Zeher, M Nagy-Vincze, Z Griger, E Zilahi, K Dankó
BioMed Research International 2015, 2015
152015
Pruritus: a sensory symptom generated in cutaneous immuno-neuronal crosstalk
AG Szöllősi, A Oláh, E Lisztes, Z Griger, BI Tóth
Frontiers in Pharmacology 13, 745658, 2022
142022
The in vitro treatment with vitamin D3 is ineffective on the expression of PKC isoenzymes, but decreases further the impaired production of IL-2 in the T lymphocytes …
G Czifra, B Tóth, I Kovács, T Bíró, Z Griger, S Baráth, T Tarr, M Zeher, ...
Rheumatology international 34, 717-720, 2014
142014
Protein kinase C-β and-δ isoenzymes promote arachidonic acid production and proliferation of MonoMac-6 cells
Z Griger, E Páyer, I Kovács, BI Tóth, L Kovács, S Sipka, T Bíró
Journal of Molecular Medicine 85, 1031-1042, 2007
142007
Effect of genetic and laboratory findings on clinical course of antisynthetase syndrome in a Hungarian cohort
K Szabó, L Bodoki, M Nagy-Vincze, A Vincze, E Zilahi, P Szodoray, ...
BioMed Research International 2018, 2018
132018
The risk of fracture and prevalence of osteoporosis is elevated in patients with idiopathic inflammatory myopathies: cross-sectional study from a single Hungarian center
A Vincze, L Bodoki, K Szabó, M Nagy-Vincze, O Szalmás, J Varga, ...
BMC Musculoskeletal Disorders 21, 1-8, 2020
112020
Efficacy and safety of IVIg (octagam 10%) in patients with active dermatomyositis. Results of a randomized, double-blind, placebo-controlled phase III trial (ProDERM study)
R Aggarwal, C Charles-Schoeman, J Schessl, Z Bata-Csorgo, ...
ARTHRITIS & RHEUMATOLOGY 72, 2020
92020
Late onset dysferlinopathy mimicking treatment resistant polymyositis.
Z Griger, M Nagy-Vincze, L Bodoki, RK Gherardi, K Dankó, T Hortobágyi
Joint Bone Spine 83 (3), 355-356, 2015
82015
Description of patients with IgG4-related disease from a Hungarian centre
A Szántó, G Nagy, CS Molnár, Z Griger, T Tarr, M Zeher
Scandinavian Journal of Rheumatology 43 (4), 334-337, 2014
82014
The system can't perform the operation now. Try again later.
Articles 1–20